Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I

التفاصيل البيبلوغرافية
العنوان: Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I
المؤلفون: A Kawakita, H Ishihama, M Nagai, Y Nishimura, H Shiraya, M Kokubo, M Kobayashi, T Imamura, K Muramatsu, Y Suzuki
المصدر: Archives of Disease in Childhood. 71:144-146
بيانات النشر: BMJ, 1994.
سنة النشر: 1994
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Erythrocytes, Side effect, medicine.medical_treatment, Lymphocyte Activation, Insulin-like growth factor, Internal medicine, Diabetes Mellitus, medicine, Humans, Insulin, Testosterone, Acanthosis Nigricans, Lymphocytes, Insulin-Like Growth Factor I, Child, biology, business.industry, Growth factor, Hyperandrogenism, Syndrome, Fibroblasts, medicine.disease, Polycystic ovary, Receptor, Insulin, Insulin receptor, Endocrinology, Pediatrics, Perinatology and Child Health, biology.protein, Female, Insulin Resistance, business, Follow-Up Studies, Polycystic Ovary Syndrome, Research Article
الوصف: Insulin-like growth factor I (IGF-I) is a useful therapeutic agent in insulin resistant diabetes mellitus due to insulin receptor disease because of its hypoglycaemic effects through the IGF-I receptor. A girl with typical type A insulin resistant syndrome was treated with IGF-I for two years and the treatment was effective in ameliorating hyperglycaemia. Overproduction of testosterone in polycystic ovaries was aggravated with this treatment, however. Therefore, IGF-I treatment may be used for glycaemic control but with caution because of its possible side effect of aggravating hyperandrogenism in these patients.
تدمد: 1468-2044
0003-9888
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ff87be9f79186166b5cf7b4668f154Test
https://doi.org/10.1136/adc.71.2.144Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....13ff87be9f79186166b5cf7b4668f154
قاعدة البيانات: OpenAIRE